AD
AOA DX Inc.
SEC filingBiotechnology · Denver, CO
Amount raised$8.1Msold at filing
Total offering$30.6M$22.5M still open
Investors in the raise40count reported to the SEC
FiledOct 15, 2025first sale Oct 1, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Surbhi SarnaDirector
Anna Milik JeterExecutive Officer
Abigail James McelhinnyExecutive Officer
Oriana Papin-ZoghbiExecutive Officer, Director
John FriedmanDirector
Alexander James FisherExecutive Officer
Executive officers, directors and promoters as listed on the Form D.